Massive french study to track virus effects on pregnant women and kids for 7 years

NCT ID NCT07412977

Not yet recruiting Knowledge-focused Sponsor: ANRS, Emerging Infectious Diseases Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will follow 5,160 pregnant women in France who have HIV, hepatitis B, hepatitis C, or an arbovirus infection (like Zika or dengue), along with their children, for up to 7 years. Researchers want to learn how these viruses and their treatments affect pregnancy, the mother's health, and the child's development. The goal is to gather information to improve care, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARBOVIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arbovirus infection cognitive disorder hepatitis hepatitis B virus infection hepatitis C virus infection hepatitis D virus infection HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARBOVIRUS INFECTIONS HBV INFECTION HCV INFECTION HDV INFECTION HIV INFECTION

Contacts and locations

Locations

Centre de Méthodologie et de Gestion de Bichat

Paris, 75018, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.